The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
BHD Foundation c/o Myrovlytis Trust
26 Cadogan Square
London SW1X 0JP UK
+44 (0) 207 052 0088
The BHD Foundation is a 501(c)(3) non-profit organization whose mission is to advance and promote research into the medical and molecular genetics of Birt-Hogg-Dubé (BHD) syndrome in order to better understand, diagnose, prevent, cure and relieve conditions caused by this disorder. BHD Foundation also fosters free dissemination of the results of such research to the public and the advancement of education of the public in the medical and molecular genetics of BHD syndrome. BHD Foundation assists in the treatment and care of persons suffering from BHD syndrome and the relief of financial hardship through the provision of grants, goods and services. BHD syndrome is a rare complex genetic skin disorder (genodermatosis) characterized by the development of skin papules generally located on the head, face and upper torso. These benign tumors (hamartomas) of the hair follicle are called fibrofolliculomas. BHD syndrome also predisposes individuals to the development of benign cysts in the lungs, repeated episodes of a collapsed lung (pneumothorax), and increased risk for developing renal neoplasia. BHD syndrome is caused by mutations in the FLCN (alias BHD) gene and is inherited as an autosomal dominant trait.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.